Omadacycline for the Treatment of Severe Chlamydia psittaci Pneumonia Complicated with Multiple Organ Failure: A Case Report

References

• Hogerwerf L, De Gier B, Baan B, et al. Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis. Epidemiol Infect. 2017;145(15):3096–3105. doi:10.1017/S0950268817002060
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhan D, Chen D, et al. Next-generation sequencing diagnosis of severe pneumonia from fulminant psittacosis with multiple organ failure: a case report and literature review. Ann Transl Med. 2020;8(6):401. doi:10.21037/atm.2020.03.17
   PubMed Web of Science ®Google Scholar
• Zhang A, Xia X, Yuan X, et al. Severe Chlamydia psittaci pneumonia complicated by rhabdomyolysis: a case series. Infect Drug Resist. 2022;15:873–881. doi:10.2147/IDR.S355024
   PubMed Web of Science ®Google Scholar
• Zhanel GG, Esquivel J, Zelenitsky S, et al. Omadacycline: a novel oral and intravenous aminomethylcycline antibiotic agent. Drugs. 2020;80(3):285–313. doi:10.1007/s40265-020-01257-4
   PubMed Web of Science ®Google Scholar
• Kohlhoff SA, Huerta N, Hammerschlag MR. In vitro activity of omadacycline against Chlamydia pneumoniae. Antimicrob Agents Chemother. 2019;63(2):e01907–18. doi:10.1128/AAC.01907-18
   Web of Science ®Google Scholar
• Zhang Z, Zhou H, Cao H, et al. Human-to-human transmission of Chlamydia psittaci in China, 2020: an epidemiological and aetiological investigation. Lancet Microbe. 2022;3(7):e512–e520. doi:10.1016/S2666-5247(22)00064-7
   PubMedGoogle Scholar
• Knittler MR, Sachse K. Chlamydia psittaci: update on an underestimated zoonotic agent. Pathog Dis. 2015;73(1):1–15. doi:10.1093/femspd/ftu007
   PubMed Web of Science ®Google Scholar
• Xiao Q, Shen W, Zou Y, et al. Sixteen cases of severe pneumonia caused by Chlamydia psittaci in South China investigated via metagenomic next-generation sequencing. J Med Microbiol. 2021;70(11). doi:10.1099/jmm.0.001456
   PubMed Web of Science ®Google Scholar
• Teng XQ, Gong WC, Qi TT, et al. Clinical analysis of metagenomic next-generation sequencing confirmed Chlamydia psittaci pneumonia: a case series and literature review. Infect Drug Resist. 2021;14:1481–1492. doi:10.2147/IDR.S305790
   PubMed Web of Science ®Google Scholar
• Li N, Li S, Tan W, et al. Metagenomic next-generation sequencing in the family outbreak of psittacosis: the first reported family outbreak of psittacosis in China under COVID-19. Emerg Microbes Infect. 2021;10(1):1418–1428. doi:10.1080/22221751.2021.1948358
   PubMed Web of Science ®Google Scholar
• Chen X, Cao K, Wei Y, et al. Metagenomic next-generation sequencing in the diagnosis of severe pneumonias caused by Chlamydia psittaci. Infection. 2020;48(4):535–542. doi:10.1007/s15010-020-01429-0
   PubMed Web of Science ®Google Scholar
• Li N, Cai Q, Miao Q, et al. High- throughput metagenomics for identification of pathogens in the clinical settings. Small Methods. 2021;5(1):2000792. doi:10.1002/smtd.202000792
   Web of Science ®Google Scholar
• Wu X, Li Y, Zhang M, et al. Etiology of severe community-acquired pneumonia in adults based on metagenomic next-generation sequencing: a prospective multicenter study. Infect Dis Ther. 2020;9(4):1003–1015. doi:10.1007/s40121-020-00353-y
   PubMed Web of Science ®Google Scholar
• Karlowsky JA, Steenbergen J, Zhanel GG. Microbiology and preclinical review of omadacycline. Clin Infect Dis. 2019;69(Suppl 1):S6–S15. doi:10.1093/cid/ciz395
   PubMed Web of Science ®Google Scholar
• Burgos RM, Rodvold KA. Omadacycline: a novel aminomethylcycline. Infect Drug Resist. 2019;12:1895–1915. doi:10.2147/IDR.S171352
   PubMed Web of Science ®Google Scholar
• Flarakos J, Du Y, Gu H, et al. Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacycline. Xenobiotica. 2017;47(8):682–696. doi:10.1080/00498254.2016.1213465
   PubMed Web of Science ®Google Scholar
• Gotfried MH, Horn K, Garrity-Ryan L, et al. Comparison of omadacycline and tigecycline pharmacokinetics in the plasma, epithelial lining fluid, and alveolar cells of healthy adult subjects. Antimicrob Agents Chemother. 2017;61(9):e01135–17. doi:10.1128/AAC.01135-17
   PubMed Web of Science ®Google Scholar
• Stets R, Popescu M, Gonong JR, et al. Omadacycline for community-acquired bacterial pneumonia. N Engl J Med. 2019;380(6):517–527. doi:10.1056/NEJMoa1800201
   PubMed Web of Science ®Google Scholar
• Balsamo G, Maxted AM, Midla JW, et al. Compendium of measures to control Chlamydia psittaci infection among humans (psittacosis) and pet birds (avian chlamydiosis), 2017. J Avian Med Surg. 2017;31(3):262–282. doi:10.1647/217-265
   PubMed Web of Science ®Google Scholar
• Cao B, Huang Y, She DY, et al. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. Clin Respir J. 2018;12(4):1320–1360. doi:10.1111/crj.12674
   PubMed Web of Science ®Google Scholar
• Cillóniz C, Torres A, Niederman M, et al. Community-acquired pneumonia related to intracellular pathogens. Intensive Care Med. 2016;42(9):1374–1386. doi:10.1007/s00134-016-4394-4
   PubMed Web of Science ®Google Scholar
• Wei C, Liu Y, Jiang A, et al. A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data. Int J Clin Pharm. 2022;44(3):709–716. doi:10.1007/s11096-022-01397-5
   PubMed Web of Science ®Google Scholar
• Ferrer P, Amelio J, Ballarín E, et al. Systematic review and meta-analysis: macrolides- and amoxicillin/clavulanate-induced acute liver injury. Basic Clin Pharmacol Toxicol. 2016;119(1):3–9. doi:10.1111/bcpt.12550
   PubMed Web of Science ®Google Scholar
• Rodvold KA, Burgos RM, Tan X, et al. Omadacycline: a review of the clinical pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2020;59(4):409–425. doi:10.1007/s40262-019-00843-4
   PubMed Web of Science ®Google Scholar
• Yang H, Huang Z, Chen Y, et al. Pharmacokinetics, safety and pharmacokinetics/pharmacodynamics analysis of omadacycline in Chinese healthy subjects. Front Pharmacol. 2022;13:869237. doi:10.3389/fphar.2022.869237
   PubMed Web of Science ®Google Scholar